Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Rock the PAC: An Evening of Music, Networking, and Advocacy
This content is an exclusive benefit for American Academy of Audiology members. If you’re a member, log in and you’ll get immediate access. Member Login…
Amplifying Audiology’s Voice: Advocacy Ambassador Program
The Academy is launching the Advocacy Ambassador Program, a grassroots advocacy program to strengthen audiology’s voice nationwide. The program will debut at the AAA Annual…
Cut Through the Noise
Let’s face it…there is a lot going on at AAA 2026, so it can be overwhelming to determine what works best for you and meets your needs. And so,…


